Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer

Akira Mizuno,Mitsuro Kanda,Daisuke Kobayashi,Chie Tanaka,Naoki Iwata,Suguru Yamada,Tsutomu Fujii,Goro Nakayama,Hiroyuki Sugimoto,Masahiko Koike,Michitaka Fujiwara,Yasuhiro Kodera
DOI: https://doi.org/10.1159/000443219
2016-01-09
Digestive Surgery
Abstract:BACKGROUND/AIMS: Gastrectomy with systemic lymphadenectomy sometimes causes excessive bleeding even by experienced surgeons. The aim of this study was to evaluate how intraoperative estimated blood loss (EBL) affected the long-term outcomes after curative surgery of patients with stage II/III gastric cancer (GC).METHODS: This study included 203 patients with stage II/III GC who did not receive perioperative blood transfusion between 1999 and 2015. The optimal cutoff and the prognostic significance of EBL were determined retrospectively.RESULTS: The median EBL was 285 ml. Receiver operating characteristic curve analysis identified 400 ml as an optimal cutoff. Patients with EBL ≥400 ml were more likely to have hepatic relapse and worse prognosis compared to those with EBL <400 ml. EBL ≥400 ml was identified as an independent prognostic factor for mortality by multivariable analysis. When patients were subdivided according to administration of adjuvant chemotherapy, there was a significant difference between the EBL ≥400 and <400 ml groups in patients who underwent surgery alone, whereas the prognosis was similar for patients of both groups who received adjuvant chemotherapy.CONCLUSION: EBL serves as a useful predictor for risk stratification after curative gastrectomy in patients with stage II/III GC.
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?